Key result
Increased expression of PDE isoforms, particularly PDE1C, in pulmonary artery smooth muscle cells from patients with pulmonary hypertension contributes to decreased cAMP and increased proliferation.
Why the study?
Does PDE1C inhibition increase cAMP accumulation and inhibit cellular proliferation in pulmonary artery smooth muscle cells from patients with pulmonary hypertension?
Does PDE1C inhibition increase cAMP accumulation and inhibit cellular proliferation in pulmonary artery smooth muscle cells from patients with pulmonary hypertension?
PDE1C is upregulated in pulmonary artery smooth muscle cells of patients with pulmonary hypertension, and its inhibition reduces cellular proliferation, highlighting it as a potential therapeutic target.
No takes yet. Share an insight, caveat, or question.
PDE1C inhibition merits preclinical testing in pulmonary hypertension; leaves open clinical translation from cellular data.
Murray et al. (2006) studied Pulmonary hypertension (idiopathic and secondary). PDE inhibitors and PDE1C-targeted siRNA vs. Control PASMC / untreated was evaluated on Expression and activity of PDE isoforms, cAMP levels, and cellular proliferation. Increased expression of PDE isoforms, particularly PDE1C, in pulmonary artery smooth muscle cells from patients with pulmonary hypertension contributes to decreased cAMP and increased proliferation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: